Coloplast
Kim Barken is an experienced professional in the field of molecular biology, currently serving as a Senior Evidence Manager at Coloplast since December 2019, following a progression from Evidence Manager. Prior to Coloplast, Kim held the position of Product Manager/Team Leader at Bifodan A/S, overseeing B2B probiotic solutions from January 2017 to November 2019. Kim's earlier career includes roles as Global Product Manager, Scientific Manager, and Scientist at Exiqon, where responsibilities spanned the qPCR product portfolio and R&D projects. Additional experience includes a Post Doc role at BioCentrum and a Research Scientist position at Novozymes. Educational qualifications include a Ph.D. in Molecular Biology from Novozymes (Industrial Ph.D. with DTU) and a Master's degree from the Technical University of Denmark.
This person is not in any teams
This person is not in any offices
Coloplast
23 followers
Coloplast develops products and services to make life easier for people with deeply personal and private medical conditions. These conditions are often associated with trauma and taboo. The more intimate the condition, the greater the requirement to come closer to customers, understand their world and develop solutions that are sensitive to their special needs. We call this Intimate Healthcare.